Walter Taal

Walter Taal

UNVERIFIED PROFILE

Are you Walter Taal?   Register this Author

Register author
Walter Taal

Walter Taal

Publications by authors named "Walter Taal"

Are you Walter Taal?   Register this Author

28Publications

979Reads

9Profile Views

Deregulated microRNAs in neurofibromatosis type 1 derived malignant peripheral nerve sheath tumors.

Sci Rep 2020 Feb 19;10(1):2927. Epub 2020 Feb 19.

Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Erasmus MC, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41598-020-59789-4DOI Listing
February 2020

Imaging necrosis during treatment is associated with worse survival in EORTC 26101 study.

Neurology 2019 06 10;92(24):e2754-e2763. Epub 2019 May 10.

From the University Medical Center & German Cancer Research Center (M.N., F.S., I.H., P.K., M.P., M.B., W.W.), Heidelberg, Germany; EORTC Headquarters (T.G., V.G.), Brussels, Belgium; Brain Tumor Center at Erasmus MC Cancer Institute (J.E.C.B., W.T., M.J.v.d.B.), Rotterdam, the Netherlands; Medical Oncology Department (A.A.B.), AUSL-Bologna-IRCCS Scienze Neurologiche, Bologna, Italy; Haaglanden Medical Center (M.J.B.T.), the Hague; Leiden University Medical Center (M.J.B.T.), the Netherlands; Institut Gustave Roussy (J.D.), Villejuif; Sorbonne Université (A.I.), Inserm, CNRS, UMR S 1127, Institut du Cerveau et de la Moelle Épinière, ICM, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière-Charles Foix, Service de Neurologie 2-Mazarin, Paris; Institut de Cancerologie de l'Ouest (ICO)-Centre Rene Gauducheau (M.C.), Saint-Herblain, France; Leuven Cancer Institute-KU Leuven (P.M.C.), Belgium; Department of Neurology and Brain Tumor Center (M.W.), University Hospital and University of Zurich, Switzerland; Institut Régional du Cancer Montpellier (M.F.); University of Lille (E.L.R.), U-1192, Inserm; CHU Lille (E.L.R.), General and Stereotaxic Neurosurgery Service; Oscar Lambret Center (E.L.R.), Neurology, Lille, France; Department of Neurology (M.P.), Medical Faculty Mannheim, Heidelberg University, Germany; and Department of Neurology (M.N.), Medical University Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000007643DOI Listing
June 2019

Worries and needs of adults and parents of adults with neurofibromatosis type 1.

Am J Med Genet A 2018 05;176(5):1150-1160

ENCORE Expertise Center for Neurodevelopmental Disorders, Erasmus Medical Center, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajmg.a.38680DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5947156PMC
May 2018

Lomustine and Bevacizumab in Progressive Glioblastoma.

N Engl J Med 2017 11;377(20):1954-1963

From the University Medical Center and German Cancer Research Center, Heidelberg, Germany (W.W., M.B., F.S., I.H., A.D., M.P.); the European Organization for Research and Treatment of Cancer, Brussels (T.G., V.G.), and Leuven Cancer Institute-KU Leuven, Leuven (P.M.C.) - both in Belgium; Haaglanden Medical Center, The Hague (M.T.), Erasmus MC Cancer Institute, Rotterdam (W.T., J.C.B., M.J.B.), and VU University Medical Center, Amsterdam (M.K.) - all in the Netherlands; the Medical Oncology Department, Azienda Unità Sanitaria Locale di Bologna-IRCCS Istituto delle Scienze Neurologiche, Bologna, Italy (A.A.B.); Institut Gustave Roussy, Villejuif (J.D.), Assistance Publique-Hôpitaux de Paris, Hôpitaux Universitaires La Pitié Salpêtrière-Charles Foix, Service de Neurologie 2-Mazarin, INSERM Unité 1127, Centre National de la Recherche Scientifique Unité Mixte de Recherche (UMR) 7225, Sorbonne Universités, University Pierre and Marie Curie 06 UMR S1127, and Institut du Cerveau et de la Moelle Épinière, Paris (A.I.), Institut de Cancerologie de l'Ouest-Centre Rene Gauducheau, Saint-Herblain (M.C.), Institut Régional du Cancer Montpellier, Montpellier (M.F.), and Centre Hospitalier Régional Universitaire de Lille, Lille (E.L.R., F.D.) - all in France; and the Departments of Oncology and Neurology, University Hospital and University of Zurich, Zurich, Switzerland (R.S., M.W.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1707358DOI Listing
November 2017

Expression and inhibition of BRD4, EZH2 and TOP2A in neurofibromas and malignant peripheral nerve sheath tumors.

PLoS One 2017 15;12(8):e0183155. Epub 2017 Aug 15.

Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0183155PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5557548PMC
October 2017

Incidence of pseudoprogression in low-grade gliomas treated with radiotherapy.

Neuro Oncol 2017 05;19(5):719-725

Department of Neuro-oncology/Neurology, Erasmus MC Cancer Institute, Rotterdam, Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/now194DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5464441PMC
May 2017

[New Dutch guideline on spinal metastasis: extended to include spinal localisations of haematological malignancies].

Ned Tijdschr Geneeskd 2015 ;159:A9101

*Namens de multidisciplinaire richtlijnwerkgroep, waarvan de samenstelling aan het eind van dit artikel vermeld staat.

View Article

Download full-text PDF

Source
September 2016

[Alarm symptoms of spinal metastases in patients with cancer].

Ned Tijdschr Geneeskd 2015 ;159:A9256

*Namens de Landelijke Richtlijncommissie Wervelmetastasen.

View Article

Download full-text PDF

Source
September 2016

Chemotherapy in glioma.

CNS Oncol 2015 23;4(3):179-92. Epub 2015 Apr 23.

Department of Neurology/Neuro-Oncology, Erasmus MC Cancer Institute, Erasmus MC University Medical Center, Groene Hilledijk 301, 3075 EA, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/cns.15.2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6088309PMC
February 2016

The impact of bevacizumab on health-related quality of life in patients treated for recurrent glioblastoma: results of the randomised controlled phase 2 BELOB trial.

Eur J Cancer 2015 Jul 17;51(10):1321-30. Epub 2015 Apr 17.

VU University Medical Center, Department of Neurology, PO Box 7057, 1007 MB Amsterdam, The Netherlands; Medical Center Haaglanden, Department of Neurology, PO Box 432, 2501 CK The Hague, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2015.03.025DOI Listing
July 2015

Treatment of large low-grade oligodendroglial tumors with upfront procarbazine, lomustine, and vincristine chemotherapy with long follow-up: a retrospective cohort study with growth kinetics.

J Neurooncol 2015 Jan 26;121(2):365-72. Epub 2014 Oct 26.

Department of Neuro-Oncology/Neurology, Erasmus MC Cancer Institute, Erasmus MC University Medical Center, Groene Hilledijk 301, 3075 EA, Rotterdam, The Netherlands,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-014-1641-9DOI Listing
January 2015

Bevacizumab alone or in combination with chemotherapy in glioblastomas?--authors' reply.

Lancet Oncol 2014 Oct;15(11):e473-4

Department of Neuro-Oncology, Erasmus MC Cancer Institute, Rotterdam, Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(14)70453-XDOI Listing
October 2014

Are we done with dose-intense temozolomide in recurrent glioblastoma?

Neuro Oncol 2014 Sep 25;16(9):1161-3. Epub 2014 Jul 25.

Dr Daniel den Hoed Cancer Center Rotterdam, The Netherlands (M.J.v.d.B.); Dept Neuro-Oncology/Neurology Erasmus MC Cancer Institute, Rotterdam, The Netherlands (M.J.v.d.B., W.T.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nou157DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4136902PMC
September 2014

Efficacy of opioid rotation to continuous parenteral hydromorphone in advanced cancer patients failing on other opioids.

Support Care Cancer 2012 Aug 23;20(8):1639-47. Epub 2011 Aug 23.

Department of Medical Oncology, Erasmus MC Daniel den Hoed Cancer Center, PO Box 5201, 3008 AE, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-011-1254-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3390689PMC
August 2012

Dose dense 1 week on/1 week off temozolomide in recurrent glioma: a retrospective study.

J Neurooncol 2012 May 7;108(1):195-200. Epub 2012 Mar 7.

Department Neurology/Neuro-oncology Unit, Erasmus MC University Hospital/Daniel den Hoed Cancer Center, Groene Hilledijk 301, 3075 EA, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-012-0832-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3337418PMC
May 2012

MGMT promoter hypermethylation is a frequent, early, and consistent event in astrocytoma progression, and not correlated with TP53 mutation.

J Neurooncol 2011 Feb 1;101(3):405-17. Epub 2010 Jul 1.

Department of Pathology, Josephine Nefkens Institute, Be320a, Erasmus MC, University Medical Center Rotterdam, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-010-0274-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3024495PMC
February 2011

Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas.

Lancet Oncol 2008 May;9(5):453-61

Department of Neuro-oncology, Daniel den Hoed Cancer Centre, Erasmus Medical Centre, Rotterdam, Netherlands.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S14702045087012
Publisher Site
http://dx.doi.org/10.1016/S1470-2045(08)70125-6DOI Listing
May 2008

Is motor inhibition during laughter due to emotional or respiratory influences?

Psychophysiology 2004 Mar;41(2):254-8

Department of Neurology and Clinical Neurophysiology, Leiden University Medical Centre, Leiden, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1469-8986.2003.00145.xDOI Listing
March 2004

A woman with multiple sclerosis and pink saliva.

Lancet Neurol 2003 Apr;2(4):254-5

Department of Neurology, Medical Centre, The Hague, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s1474-4422(03)00354-5DOI Listing
April 2003